Vinblastine sulfate

Vinblastine sulfate__Cell cycle blocker AMG 234

Product Name Vinblastine sulfate
Description

Cell cycle blocker

Purity >98%
CAS No. 143-67-9
Molecular Formula C46H58N4O9•H2SO4
Molecular Weight 909.1
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO, methanol or water (25 mg/ml).
Source Synthetic
Appearance White powder.
SMILES C@@178C@@H(N(C2=C1C=C(C(=C2)OC)C@@5(C3=C(C4=C(NH3)C=CC=C4)CCN6CC@@H(C5)CC@(O)(C6)CC)C(OC)=O)C)C@(O)(email protected(OC
InChI InChI=1S/C46H58N4O9.H2O4S/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)
InChIKey KDQAABAKXDWYSZ-PNYVAJAMSA-N
Safety Phrases Classification: D1B- Toxic Material Causing Immediate and Serious Toxic Effects, Toxic by ingestion, D2B- Toxic Material Causing Other Toxic Effects, Moderate skin irritant, Moderate eye irritant, Mutagen
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
Hazard statements:
H302- Harmful if swallowed.
H315- Causes skin irritation.
H318- Causes serious eye damage.
H335- May cause respiratory irritation.
Precautionary statements:
P261- Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P280- Wear protective gloves/ eye protection/ face protection.
P305 + P351 + P338- IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Cite This Product Vinblastine sulfate (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-407)
Alternative Names Vincaleukoblastine
Research Areas Cancer, Autophagy
PubChem ID 5388983
Scientific Background Vinblastine sulfate is used clinically as a cancer chemotherapeutic agent. It disrupts normal microtubule assembly. Vinblastine also inhibits autophagy by obstructing autophagosome maturation and by stopping the fusion event of autophagosomes with lysosomes.
References 1. Veldhoen R.A., et al. (2013) Oncogene. 32(6): 736-46.
2. Adiseshaiah P.P., et al. (2013) Cancer Lett. 337(2): 254-65.